| Financial Year |
March 31 2023 |
| Monetary Funds |
27,107,954.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
30,768,964.37 |
| Advances to Suppliers |
1,444,000.75 |
| Other Receivables |
1,795,352.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
49,221,169.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
885,970.27 |
| Total Current Assets |
112,451,559.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
151,174,012.47 |
| Under-construction Projects |
405,010.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,331,019.30 |
| R&D expenses |
-- |
| Goodwill |
2,198,559.52 |
| Long-Term Deferred and Prepaid Expenses |
2,171,245.16 |
| Deferred Income Tax Assets |
724,280.27 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
171,758,065.49 |
| Total Assets |
284,209,624.52 |
| Short-Term Loans |
104,503,818.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
46,724,302.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,641,822.95 |
| Taxes Payable |
1,418,264.88 |
| Interest Payable |
-- |
| Dividend Payable |
23,403.36 |
| Other payables |
49,358,968.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,599,458.28 |
| Other Current Liabilities |
438,651.21 |
| Sub-Total of Current Liabilities |
216,641,859.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,430,319.76 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
73,061,911.00 |
| Total Liabilities |
289,703,770.38 |
| Paid-In Capital(Or Share Stock) |
121,778,885.00 |
| Capital Surplus |
72,787,915.98 |
| Surplus Reserve |
24,181,414.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-242,430,587.60 |
| Minority Stockholder's Interest |
18,188,226.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-23,682,372.25 |
| Owner's Equity（Stockholder's Equity） |
-5,494,145.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
284,209,624.52 |
